Review Article

[Retracted] MicroRNAs in Hepatocellular Carcinoma: Carcinogenesis, Progression, and Therapeutic Target

Table 2

Upregulated oncogenic miRNAs in HCC.

miRNATarget genesCharacteristicsReferences

MiR-15aBcl-2, cyclin D1, AKT3Proliferation, apoptosis[65]
MiR-16-1Bcl-2, cyclin D1, AKT3Proliferation, apoptosis[65]
MiR-17c-Myc, E2FAngiogenesis[66, 67]
MiR-18c-Myc, E2FAngiogenesis[66, 67]
MiR-19c-Myc, E2FAngiogenesis[66, 67]
MiR-20ac-Myc, E2FAngiogenesis[66, 67]
MiR-21PTENmetastasis[68]
MiR-25BimApoptosis[69]
MiR-92-1c-Myc, E2FAngiogenesis[66, 67]
MiR-93BimApoptosis[69]
MiR-106bBimApoptosis[69]
MiR-148aPTENMetastasis[70]
MiR-155RhoA, TLRMetastasis[56, 71]
MiR-216aPTENMetastasis[72]
MiR-221Bmf; CDKN1B/p27/Kip1; CDKN1C/p57/Kip2, PTENApoptosis; proliferation, angiogenesis[73ā€“77]
MiR-222AKT, PTENMetastasis, angiogenesis[51, 74, 78]
MiR-224Bcl-2, Bcl-wApoptosis[79]
MiR-519dPTENMetastasis[80]